AzTrials
AzTrials

Lumbosacral RadiculopathyNCT06558383

Augmented Posterior Oblique Sling Activation on Lumbopelvic Recruitment Pattern in Lumbosacral Radiculopathy

A study testing augmented posterior oblique sling activation and selected physical therapy program in people with Lumbosacral Radiculopathy, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study aims to determine the impact of augmented posterior oblique sling activation on lumbopelvic recruitment pattern and functional outcomes in patients with unilateral lumbosacral radiculopathy. Read more about this study

Who is it for?
Ages 30 to 46 years, women only
Conditions the study is for
Lumbosacral Radiculopathy
What is being tested?
augmented posterior oblique sling activation and selected physical therapy program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Sep 2024to 20 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 46 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age ranges from 30 to 46
  • L5/S1 disc herniation.
  • Duration of pain is more than three months.
  • body mass index less than 30 kg/cm2
  • ability to perform prone hip extension task with no pain
  • impaired lumbopelvic stability (<5 mmHg pressure difference from baseline to end prone hip extension task)
  • moderate to severe lumbosacral radicular pain

Who cannot join

  • Red flags: spinal tumors, cauda equina syndrome, spinal fractures, osteoporosis, infection.
  • Bilateral symptoms.
  • Spondylolisthesis, spondylitis, and spinal canal stenosis.
  • Previous lumbopelvic or hip surgery or injection
  • Any hip structural abnormality such as malformations, impingements and degeneration.
  • Postural deviations such as scoliosis, kyphosis, lateral shift.
  • True leg length discrepancy.
  • Pregnancy and Gynecological problems.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • faculty of physical therapy Cairo university

    Giza

Other trials in Egypt

About this study

Official title: Augmented Posterior Oblique Sling Activation on Lumbopelvic Recruitment Pattern and Functional Outcomes in Lumbosacral Radiculopathy Patients

The current study aims to determine the impact of augmented posterior oblique sling activation on lumbopelvic recruitment pattern and functional outcomes in patients with unilateral lumbosacral radiculopathy.

Read the detailed description

Low back pain is now the leading cause of disability worldwide. Back pain and its related disability have a huge impact on individuals, communities, and healthcare systems. It reduces an individual's ability to participate in work which in turn negatively affects their quality of life. Also, it has major economic consequences through increasing the cost of health care and work absenteeism. Among the many differentials of low back pain, the most common cause is lumbosacral radiculopathy. Patients with low back pain showed uncontrolled lumbopelvic mobility while performing hip extension movement in functional activities. In patients with back pain, there is over-activation of the hamstrings and erector spinae and delayed or absent contraction of the gluteus maximus. Clinically, this pattern is observed as an anterior pelvic tilt with increased extension in the lumbar spine as the patient lifts the leg into extension. So, repetition of this abnormal pattern in patients with lumbosacral radiculopathy may result in mechanical and compressive stresses in the lumbar spine and magnify the patient's symptoms. Despite the role of POSM in improving spinal mobility and stability. And stabilizing the lumbopelvic joint, there are no previous studies investigating the impact of activation posterior oblique activation on this abnormal lumbopelvic recruitment and functional outcomes in patients with lumbosacral radiculopathy.

Being tested
augmented posterior oblique sling activation, selected physical therapy program
Keywords
posterior oblique sling, recruitment pattern, lumbar radiculopathy
Medical subject headings
Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • augmented posterior oblique sling activationOther

    activation of posterior oblique sling program for 18 sessions, three sessions per week for six weeks in the form of:

    • drop and catch technique
    • modified prone hip extension exercises
    • trunk and leg dissociation task
  • selected physical therapy programOther

    selected physical therapy program for 18 sessions, three sessions per week for six weeks in form of soft tissue techniques, mobilization and manipulation of lumbar spine, and neurodynamics and stabilization exercises

Study groups in NCT06558383
Study groupRoleWhat they receive
control group -Active comparatorControl group (A): Twenty patients will receive selected physical therapy program for 18 sessions, three sessions per week for six weeks in form of soft tissue techniques, mobilization and manipulation of lumbar spine, and neurodynamics.
Receives: Other: selected physical therapy program
study groupActive comparatorStudy group (B): Twenty patients will receive augmented activation of posterior oblique sling in addition to selected physical therapy program, 18 sessions, three sessions per week for six week
Receives: Other: augmented posterior oblique sling activation; Other: selected physical therapy program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. surface EMG unit

    The electromyographic pattern of activation of lumbopelvic musculature (sequence and level of activity) will be measured during prone hip extension testing using surface EMG unit.

    Measured: measurements will be done 3 days before the start of the treatment program and will be done after 3 days post intervention

  2. Pressure biofeedback unit

    it will be used to assess pelvic motion. the pressure sensor of the pressure biofeedback unit will be placed anteriorly between the patients' ilium and the testing table. The amount of pressure applied by the patient on the sensor at rest will be recorded then, the amount of pressure applied by patients at prone hip extension at 10 degrees will be recorded.

    Measured: measurements will be done 3 days before the start of the treatment program and will be done after 3 days post intervention

Secondary outcomes (3)
  1. pressure algometry

    The pressure algometry will used to measure pressure pain threshold in low back area and in sciatic valleix.

    Measured: measurements will be done 3 days before the start of the treatment program and will be done after 3 days post intervention

  2. Arabic version of Oswestry Low Back Pain Disability Questionnaire

    back pain-related disability will be assessed using using the Arabic version of Oswestry Low Back Pain Disability Questionnaire.It is a 10-item self-reported questionnaire. The patient will be asked to answer every question and mark only the box that most closely describes his problem. Each question will be assessed on a six-point scale ranging from 0 (no disability) to 5 (major disability). The score is determined by adding each item score together. The overall score is out of 50 . Higher scores represent greater disability.

    Measured: measurements will be done 3 days before the start of the treatment program and will be done after 3 days post intervention

  3. back pain intensity using the Visual analogue scale

    The subject will be asked to make a handwritten mark on a 100 mm line (10cm). This line represents a continuum between no pain or discomfort (zero), and the worst pain (10) the patient could feel. Measurements from the starting point of the scale to the patients' marks will be recorded and interpreted as their pain intensity. Higher scores represent greater pain.

    Measured: measurements will be done 3 days before the start of the treatment program and will be done after 3 days post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2024
  2. Study start1 Sep 2024
  3. Primary completion20 Sep 2025
  4. Study completion20 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial. True experimental research design study
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06558383
Sponsor's protocol ID
P.T.REC/012/005233
Status last verified
Aug 2024
First submitted
14 Aug 2024
Last updated
16 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing augmented posterior oblique sling activation and selected physical therapy program in people with Lumbosacral Radiculopathy, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

surface EMG unit (time frame: measurements will be done 3 days before the start of the treatment program and will be done after 3 days post intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in